AstraZeneca says U.S. to buy additional 500,000 Evusheld doses

AstraZeneca said on Wednesday the U.S. government has agreed to purchase an additional 500,000 doses of its antibody cocktail Evusheld used to prevent COVID-19.

The company said the delivery of the doses was expected in the first quarter of 2022 and additional details about the deal would be announced in the coming weeks.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)